Find therapies in clinical trials near you – page 8

Study on Infliximab and Tocilizumab for Patients with Refractory or Relapsing Takayasu Arteritis

Study on Infliximab and Tocilizumab for Patients with Refractory or Relapsing Takayasu Arteritis

Study on Dobutamine and Tocilizumab for Patients with Heart Attack at High Risk of Cardiogenic Shock

Study on Dobutamine and Tocilizumab for Patients with Heart Attack at High Risk of Cardiogenic Shock

Study of Mosunetuzumab and Zanubrutinib for Patients with Relapsed or Refractory Follicular Lymphoma

Study of Mosunetuzumab and Zanubrutinib for Patients with Relapsed or Refractory Follicular Lymphoma

Study on Tocilizumab and Steroids for Patients with Giant Cell Arteritis and Cerebrovascular Involvement

Study on Tocilizumab and Steroids for Patients with Giant Cell Arteritis and Cerebrovascular Involvement

Study of TAK-280, Tocilizumab, and Siltuximab for Patients with Advanced or Metastatic Cancer

Study of TAK-280, Tocilizumab, and Siltuximab for Patients with Advanced or Metastatic Cancer

Study on the Safety and Effects of THOR-707 and Drug Combination in Adults with Advanced or Metastatic Cancer

Study on the Safety and Effects of THOR-707 and Drug Combination in Adults with Advanced or Metastatic Cancer

Study of Epcoritamab for Patients with Relapsed, Progressive, or Refractory B-Cell Lymphoma

Study of Epcoritamab for Patients with Relapsed, Progressive, or Refractory B-Cell Lymphoma

Study Comparing Epcoritamab with Chemotherapy for Patients with Relapsed or Refractory B-cell Lymphoma

Study of Elranatamab, Dexamethasone, and Diphenhydramine Hydrochloride for Patients with High-Risk Smoldering Multiple Myeloma

Study of Elranatamab, Dexamethasone, and Diphenhydramine Hydrochloride for Patients with High-Risk Smoldering Multiple Myeloma

Study on the Safety and Effectiveness of Baricitinib and Tocilizumab for Children with Systemic Juvenile Idiopathic Arthritis

Study on the Safety and Effectiveness of Baricitinib and Tocilizumab for Children with Systemic Juvenile Idiopathic Arthritis

Study on Talquetamab and Tocilizumab for Patients with Relapsed or Refractory Multiple Myeloma

Study on Talquetamab and Tocilizumab for Patients with Relapsed or Refractory Multiple Myeloma

Study on the Safety and Effects of Englumafusp Alfa with Obinutuzumab and Glofitamab for Patients with Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma

Study on the Safety and Effects of Englumafusp Alfa with Obinutuzumab and Glofitamab for Patients with Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma